Trademark: 79169111
Word
IDS-ISYS 1,25 VITDXP
Status Date
Friday, December 16, 2022
Registration Number
4966871
Registration Date
Tuesday, May 31, 2016
Filing Date
Wednesday, February 18, 2015
Published for Opposition
Tuesday, March 15, 2016
Cancellation Date
Friday, December 16, 2022
9 Instruments for testing, processing or detecting biological samples for laboratory purposes, namely, an automatic analytical device for quantifying levels of 1,25-dihydroxyvitamin D; computer software for use in analyzing and managing biological data
5 Reagents for use in diagnostic tests for medical purposes; chemical diagnostic reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; diagnostic testing materials including delipidation agent and 1,25-dihydroxyvitamin D binding partner for medical use, namely, diagnostic reagents and assays for testing body fluids; reagents for use in medical diagnostic tests; chemical preparations for testing blood for medical purposes; diagnostic kit comprising of diagnostic reagents for medical use
1 Diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical products, namely, 1,25-dihydroxyvitamin D for diagnostic use, namely, diagnostic preparations for scientific or research use; assays and reagents for research purposes; biological and biochemical reagents for research and non-medical commercial use
10 Diagnostic apparatus for medical purposes for detecting 1,25-dihydroxyvitamin D deficiency; diagnostic instruments for medical use for differential diagnosis of hypercalcaemia, renal disease, secondary hyperparathyroidism, hypocalcaemia and in distinguishing Vitamin D resistance syndromes from Vitamin D deficiency; medical diagnostic testing instruments for use in immunoassay procedure; medical diagnostic instruments for monitoring 1,25 dihydroxyvitamin D levels for diagnosing calcium metabolism disorders and their treatments, used in conjunction with other clinical and laboratory data; blood testing apparatus
Oct 2, 2023
Total Invalidation Processed By The Ib
Sep 9, 2023
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 9, 2023
Invalidation Processed
Aug 16, 2023
Total Invalidation Of Reg Ext Protection Created
Dec 16, 2022
Cancelled Section 71
May 31, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 23, 2016
Final Decision Transaction Processed By Ib
Sep 1, 2016
Final Disposition Notice Sent To Ib
Sep 1, 2016
Final Disposition Processed
Aug 31, 2016
Final Disposition Notice Created, To Be Sent To Ib
May 31, 2016
Registered-Principal Register
Mar 15, 2016
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2016
Published For Opposition
Mar 11, 2016
Notification Processed By Ib
Feb 24, 2016
Notification Of Possible Opposition Sent To Ib
Feb 24, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 24, 2016
Notification Of Notice Of Publication E-Mailed
Jan 29, 2016
Approved For Pub - Principal Register
Jan 29, 2016
Examiner's Amendment Entered
Jan 29, 2016
Notification Of Examiners Amendment E-Mailed
Jan 29, 2016
Examiners Amendment E-Mailed
Jan 29, 2016
Examiners Amendment -Written
Jan 12, 2016
Teas/Email Correspondence Entered
Jan 12, 2016
Correspondence Received In Law Office
Jan 12, 2016
Teas Response To Office Action Received
Aug 15, 2015
Refusal Processed By Ib
Jul 29, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jul 29, 2015
Refusal Processed By Mpu
Jul 29, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jul 28, 2015
Non-Final Action Written
Jul 28, 2015
Application Filing Receipt Mailed
Jul 24, 2015
Assigned To Examiner
Jul 24, 2015
New Application Office Supplied Data Entered
Jul 23, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
